Jeff Jones

Stock Analyst at Oppenheimer

(0)
# 5000
Out of 5,338 analysts
108
Total ratings
11.25%
Success rate
-31.71%
Average return
27 Stocks
Name Action PT Current % Upside Ratings Updated
ALMS Alumis
Maintains: Outperform
26 25
5.3 371.7% 2 May 15, 2025
YMAB Y-mAbs Therapeutics
Maintains: Outperform
21 20
3.87 416.8% 2 May 14, 2025
ZURA Zura Bio
Maintains: Outperform
19 17
1.2 1316.67% 4 May 9, 2025
CRVS Corvus Pharma
Reiterates: Outperform
15 17
3.57 376.19% 5 May 9, 2025
IMCR Immunocore Holdings
Maintains: Outperform
85 86
29.02 196.35% 2 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
60 56
7.22 675.62% 9 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
28 18
8.81 104.31% 4 Jan 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 5 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
22 16
2.41 563.9% 7 Nov 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
13 11
1.29 752.71% 7 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
10 9
1.21 643.8% 10 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
52 56
29.96 86.92% 4 Sep 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
35 39
19.24 102.7% 2 Sep 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
48 45
1.36 3208.82% 6 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 4 Jun 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Perform
n/a
n/a n/a 3 Apr 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
32 30
n/a n/a 3 Feb 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
13 15
n/a n/a 3 Jan 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 3 Jun 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
1920
2.18 87973.39% 3 May 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
13
n/a n/a 2 May 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
15
0.83 1707.23% 5 May 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
75
0.91 8141.76% 2 Mar 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
125 150
n/a n/a 6 Mar 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
1600 1100
1.66 66165.06% 2 Nov 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
193
n/a n/a 1 Jul 18, 2022